Home
>
National Drug Code (NDC)
>
VIMOVO
VIMOVO - 16590-957-30 - (NAPROXEN AND ESOMEPRAZOLE MAGNESIUM)
Drug Information of VIMOVO
| Product NDC: | 16590-957 |
| Proprietary Name: | VIMOVO |
| Non Proprietary Name: | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
| Active Ingredient(s): | 20; 375 mg/1; mg/1 & nbsp; NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VIMOVO
| Product NDC: | 16590-957 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022511 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110701 |
Package Information of VIMOVO
| Package NDC: | 16590-957-30 |
| Package Description: | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (16590-957-30) |
NDC Information of VIMOVO
| NDC Code | 16590-957-30 |
| Proprietary Name | VIMOVO |
| Package Description | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (16590-957-30) |
| Product NDC | 16590-957 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110701 |
| Marketing Category Name | NDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | ESOMEPRAZOLE MAGNESIUM; NAPROXEN |
| Strength Number | 20; 375 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
